跳至主要内容
临床试验/NCT04259372
NCT04259372已完成不适用

Analysis of T Cell Metabolism and Immune Phenotype During the Course of Acute Myeloid Leukemia

University of Freiburg0 个研究点目标入组 77 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
77
主要终点
T cell phenotype

研究概览

简要总结

The objective of this study was to analyze the T cell metabolism and immune phenotype in AML patients during the course of the disease before and after allo-HCT.

详细描述

Patients who experience relapse of acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (allo-HCT) have a dismal prognosis. Infusion of donor T cells can induce graft-versus-leukemia (GVL) effects, indicating the importance of intact T cell function for leukemia control. Recent studies have shown the importance of metabolic fitness for an effective T cell response.

In this study we have analyzed the T cell metabolism and immune phenotype in AML patients at different time points before and after allo-HCT.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • confirmed diagnosis of AML
  • age ≥ 18 years
  • peripheral blood sample available
  • written informed consent
  • ability to understand the nature of the study and the study related procedures and to comply with them

排除标准

  • age < 18 years
  • lack of informed consent
  • patients that cannot be classified in one of the 3 groups

结局指标

主要结局

T cell phenotype

时间窗: 4 years

T cell cytokine and effector molecule production

T cell metabolism

时间窗: 4 years

Extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) determined by live-cell metabolic assay using the Seahorse Analyzer

次要结局

  • Metabolite abundance in serum(4 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Zeiser

Director of the Division of Tumor Immunology

University of Freiburg

相似试验